The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): Cross-cultural validation and relation with pollen counts

npj Primary Care Respiratory Medicine

Volumn 25, Issue , 2015, Pages

  Van Der Leeuw, Sander ^a   Van Der Molen, Thys ^a   Dekhuijzen, Pn Richard ^b   Fonseca, Joao A ^c   Van Gemert, Frederik A ^a   Gerth Van Wijk, Roy ^d   Kocks, Janwillem Wh ^a   Oosterom, Helma ^a   Riemersma, Roland A ^a   Tsiligianni, Ioanna G ^a   De Weger, Letty A ^e   Oude Elberink, Joanne Ng ^a   Flokstra De Blok, Bertine Mj ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c University of Porto   (Portugal)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CONSTRUCT VALIDITY; CONTROL OF ALLERGIC RHINITIS AND ASTHMA TEST; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; CROSS SECTIONAL VALIDITY; DISEASE ASSESSMENT; FEMALE; GLOBAL RATING OF CHANGE; HUMAN; INTERNAL CONSISTENCY; LONGITUDINAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; POLLEN ANALYSIS; POLLEN COUNT; PSYCHOMETRY; QUESTIONNAIRE; STATISTICAL MODEL; TEST RETEST RELIABILITY; VALIDITY; VISUAL ANALOG SCALE; ADOLESCENT; AGED; CULTURAL FACTOR; MIDDLE AGED; PRIMARY HEALTH CARE; REPRODUCIBILITY; RHINITIS, ALLERGIC; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84937057346     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2014.107     Document Type: Article

References (32)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. ARIA update 2008: allergic rhinitis and its effect on asthma. Allergologie 2009; 32: 306-319.
2. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001; 107: 73-80.
3. Terreehorst I, Oosting A, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, Hak E et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy 2002; 32: 1160-1165.
4. Sole D, Camelo-Nunes I, Wandalsen G, Melo K, Naspitz C. Is rhinitis alone or associated with atopic eczema a risk factor for severe asthma in children? Pediatr Allergy Immunol 2005; 16: 121-125.
5. Bousquet J, Gaugris S, Kocevar V, Zhang Q, Yin DD, Polos PG et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy 2005; 35: 723-727.
6. Bousquet J, Bodez T, Gehano P, Klossek JM, Liard F, Neukirch F et al. Implementation of guidelines for allergic rhinitis in specialist practices. A randomized pragmatic controlled trial. Int Arch Allergy Immunol 2009; 150: 75-82.
7. Church MK, Maurer M, Simons FER, Bindslev-Jensen C, van Cauwenberge P, Bousquet J et al. Risk of first-generation H-1-antihistamines: a GA2LEN position paper. Allergy 2010; 65: 459-466.
8. Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58: 289-294.
9. Kilpelainen M, Terho E, Helenius H, Koskenvuo M. Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001; 56: 377-384.
10. Fischer PE, Grabbe Y, Nolting H. Development and validation of a screening questionnaire for allergy airway diseases (ASF Screening Questionnaire). Allergologie 2006; 29: 393-402.
11. Wasserfallen J, Gold K, Schulman K, Baraniuk J. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol 1997; 100: 16-22.
12. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009; 18: 300-305.
13. Braunstahl G, Fokkens W. Nasal involvement in allergic asthma. Allergy 2003; 58: 1235-1243.
14. Bousquet J, Bousquet P, Godard P, Daures J. The public health implications of asthma. Bull World Health Organ 2005; 83: 548-554.
15. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
16. Juniper E, O'Byrne P, Guyatt G, Ferrie P, King D. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902-907.
17. Nathan R, Sorkness C, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65.
18. Vollmer W, Markson LE, O'Connor E, Sanocki LL, Fitterman L, Berger M et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160: 1647-1652.
19. Nogueira-Silva L, Martins SV, Cruz-Correia R, Azevedo LF, Morais-Almeida M, Bugalho-Almeida A et al. Control of allergic rhinitis and asthma test-a formal approach to the development of a measuring tool. Respir Res 2009; 10: 52.
20. Fonseca JA, Nogueira-Silva L, Morais-Almeida M, Azevedo L, Sa-Sousa A, Branco-Ferreira M et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010; 65: 1042-1048.
21. Fonseca J, Nogueira-Silva L, Morais-Almeida M, Sa-Sousa A, Azevedo LF, Ferreira J et al. Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time. Clin Transl Allergy 2012; 2: 16.
22. Azevedo P, Correia-de-Sousa J, Bousquet J, Bugalho-Almeida A, Del Giacco SR, Demoly P et al. Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J 2013; 22: 112-116.
23. Juniper E, Bousquet J, Abetz L, Bateman EGOAL Comm. Identifying 'wellcontrolled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006; 100: 616-621.
24. Bousquet P, Combescure C, Klossek J, Daures J, Bousquet J. Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis. J Allergy Clin Immunol 2009; 123: 1349-1354.
25. Jaeschke R, Singer J, Guyatt G. Measurement of health-status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.
26. D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007; 62: 976-990.
27. Terwee CB, Bot SDM, de Boer MR, van der Windt DA, Knol DL, Dekker J et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
28. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010; 10: 22.
29. Copay AG, Subach BR, Glassman SD, Polly Jr DW, Schuler TC. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7: 541-546.
30. Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000; 85: 338-347.
31. de Weger LA, Beerthuizen T, Gast-Strookman JM, van der Plas DT, Terreehorst I, Hiemstra PS et al. Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis. Clin Transl Allergy 2011; 1: 18.
32. de Bruin-Weller M, Weller F, De Monchy J. Repeated allergen challenge as a new research model for studying allergic reactions. Clin Exp Allergy 1999; 29: 159-165.